EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU)

CUSIP: G3141W114

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / UNIT 10/23/2027
Total 13F shares
5,060,629
Share change
-3,429,915
Total reported value
$50,907,000
Price per share
$10.06
Number of holders
23
Value change
-$36,795,972
Number of buys
6
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP G3141W114?
CUSIP G3141W114 identifies EUCRU - EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) as of Q1 2021

As of 31 Mar 2021, EUCRATES BIOMEDICAL ACQU COR - UNIT 10/23/2027 (EUCRU) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,060,629 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PRICE T ROWE ASSOCIATES INC /MD/, BVF INC/IL, Magnetar Financial LLC, Altium Capital Management LP, Verition Fund Management LLC, HealthCor Management, L.P., Sio Capital Management, LLC, Rock Springs Capital Management LP, and KINGDON CAPITAL MANAGEMENT, L.L.C.. This page lists 23 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.